Dysregulated adipokines in the pathogenesis of type 2 diabetes and vascular disease

British Journal of Diabetes and Vascular Disease

Volumn 12, Issue 5, 2012, Pages 249-254

  Brown, James E ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Adipokines; adiponectin; leptin; obesity; type 2 diabetes; vascular disease

Indexed keywords

ADIPOCYTOKINE; ADIPOLIN; ADIPONECTIN; APELIN; GLUCOSE; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMENTIN; RESISTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CYTOKINE RELEASE; FOOD INTAKE; GLUCONEOGENESIS; GLUCOSE METABOLISM; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID OXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; SKELETAL MUSCLE; VASCULAR DISEASE;

EID: 84870035480     PISSN: 14746514     EISSN: 17534305     Source Type: Journal    
DOI: 10.1177/1474651412464794     Document Type: Article

References (73)

1. Deng Y, Scherer PE. Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann NY Acad Sci. 2010 ; 1212: E1 - E19
2. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003 ; 289: 76-79
3. Sternby NH, Fernandez-Britto JE, Nordet P. Pathobiological determinants of atherosclerosis in youth (PBDAY Study), 1986-96. Bulletin of the World Health Organization. 1999 ; 77: 250-257
4. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest. 1999 ; 104: 787-794
5. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994 ; 372: 425-432
6. Brown JE, Thomas S, Digby JE, Dunmore SJ. Glucose induces and leptin decreases expression of uncoupling protein-2 mRNA in human islets. FEBS letters. 2002 ; 513: 189-92
7. Kulkarni RN, Wang ZL, Wang RM, Hurley JD, et al. Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest. 1997 ; 100: 2729-2736
8. Shimizu H, Ohtani K, Tsuchiya T, et al. Leptin stimulates insulin secretion and synthesis in HIT-T 15 cells. Peptides. 1997 ; 18: 1263-1266
9. Pallett AL, Morton NM, Cawthorne MA, Emilsson V. Leptin inhibits insulin secretion and reduces insulin mRNA levels in rat isolated pancreatic islets. Biochem Biophys Res Commun. 1997 ; 238: 267-270
10. Bates SH, Gardiner JV, Jones RB, et al. Acute stimulation of glucose uptake by leptin in l6 muscle cells. Horm Metab Res. 2002 ; 34: 111-5
11. Hamed EA, Zakary MM, Ahmed NS, Gamal RM. Circulating leptin and insulin in obese patients with and without type 2 diabetes mellitus: relation to ghrelin and oxidative stress. Diabetes Res Clin Pract. 2011 ; 94: 434-441
12. Enriori PJ, Evans AE, Sinnayah P, Cowley MA. Leptin resistance and obesity. Obesity. 2006 ; 14: 254S - 258S
13. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999 ; 257: 79-83
14. Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med. 2008 ; 14: 741-751
15. Waki H, Yamauchi T, Kamon J, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem. 2003 ; 278: 40352-40363
16. Mullen KL, Pritchard J, Ritchie I, et al. Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats. Am J Physiol Regul Integr Comp Physiol. 2009 ; 296: R243 - R251
17. Miller RA, Qingwei C, Le Lay J, et al. Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling. J Clin Invest. 2011 ; 121: 2518-2528
18. Dray C, Knauf C, Daviaud D, et al. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab. 2008 ; 8: 437-445
19. Yue P, Jin H, Aillaud M, et al. Apelin is necessary for the maintenance of insulin sensitivity. Am J Physiol Endocrinol Metab. 2010 ; 298: E59-67
20. Vidal-Puig A, O'Rahilly S. Resistin:a new link between obesity and insulin resistance?. Clin Endocrinol. 2001 ; 55: 437-438
21. Silha JV, Krsek M, Skrha JV, et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol. 2003 ; 149: 331-335
22. Lee JH, Chan JL, Yiannakouris N, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab. 2003 ; 88: 4848-4856
23. Vozarova de Courten B, Degawa-Yamauchi M, Considine RV, Tataranni PA. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes. 2004 ; 53: 1279-1284
24. Lewandowski KC, Szosland K, O'Callaghan C, et al. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices. Mol Genet Metab. 2005 ; 85: 61-69
25. Iqbal N, Seshadri P, Stern L, et al. Serum resistin is not associated with obesity or insulin resistance in humans. Eur Rev Med Pharmacol Sci. 2005 ; 9: 161-165
26. Utzschneider KM, Carr DB, Tong J, et al. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia. 2005 ; 48: 2330-2333
27. Heilbronn LK, Rood J, Janderova L, et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab. 2004 ; 89: 1844-1848
28. Brown JE, Onyango DJ, Dunmore SJ. Resistin down-regulates insulin receptor expression, and modulates cell viability in rodent pancreatic beta-cells. FEBS letters. 2007 ; 581: 3273-32736
29. Danielsson T, Fredriksson L, Jansson L, Henriksnas J. Resistin increases islet blood flow and decreases subcutaneous adipose tissue blood flow in anaesthetized rats. Acta Physiol (Oxf). 2009 ; 195: 283-288
30. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin:a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005 ; 307: 426-430
31. Haider DG, Schaller G, Kapiotis S, et al. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia. 2006 ; 49: 1909-1914
32. Revollo JR, Korner A, Mills KF, et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 2007 ; 6: 363-375
33. Brown JE, Onyango DJ, Ramanjaneya M, et al. Visfatin regulates insulin secretion, insulin receptor signalling and mRNA expression of diabetes-related genes in mouse pancreatic beta-cells. J Mol Endocrinol. 2010 ; 44: 171-178
34. Lan J, Chen X, Wang S, et al. The relationship between visfatin and HOMA-IR in hypertensive patients, and the effect of antihypertensive drugs on visfatin and HOMA-IR in hypertensive patients with insulin resistance. Diabetes Res Clin Pract. 2011 ; 94: 71-76
35. Straburzynska-Lupa A, Nowak A, Pilaczynska-Szczesniak L, et al. Visfatin, resistin, hsCRP and insulin resistance in relation to abdominal obesity in women with rheumatoid arthritis. Clin Exp Rheumatol. 2010 ; 28: 19-24
36. Kouyama K, Miyake K, Zenibayashi M, et al. Association of serum MCP-1 concentration and MCP-1 polymorphism with insulin resistance in Japanese individuals with obese type 2 diabetes. Kobe J Med Sci. 2007 ; 53: 345-354
37. Suzuki T, Imai J, Yamada T, et al. Interleukin-6 enhances glucose-stimulated insulin secretion from pancreatic beta-cells: potential involvement of the PLC-IP3-dependent pathway. Diabetes. 2011 ; 60: 537-47
38. Besedovsky HO, Del Rey A. Interleukin-1 resets glucose homeostasis at central and peripheral levels: relevance for immunoregulation. Neuroimmunomodulation. 2010 ; 17: 139-141
39. Enomoto T, Ohashi K, Shibata R, et al. Adipolin/C1qdc2/CTRP12 protein functions as an adipokine that improves glucose metabolism. J Biol Chem. 2011 ; 286: 34552-34558
40. Choi JH, Rhee EJ, Kim KH, et al. Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome. Eur J Endocrinol. 2011 ; 165: 789-96
41. Lamers D, Famulla S, Wronkowitz N, et al. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes. 2011 ; 60: 1917-1925
42. Fan Y, Ye J, Shen F, et al. Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. J Cereb Blood Flow Metab. 2008 ; 28: 90-98
43. Adya R, Tan BK, Chen J, Randeva HS. Pre-B cell colony enhancing factor (PBEF)/visfatin induces secretion of MCP-1 in human endothelial cells: role in visfatin-induced angiogenesis. Atherosclerosis. 2009 ; 205: 113-119
44. Arefieva TI, Kukhtina NB, Antonova OA, Krasnikova TL. MCP-1-stimulated chemotaxis of monocytic and endothelial cells is dependent on activation of different signaling cascades. Cytokine. 2005 ; 31: 439-446
45. Berstad P, Seljeflot I, Veierod MB, et al. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1. Clin Sci (Lond). 2003 ; 105: 13-20
46. Pirvulescu M, Manduteanu I, Gan AM, et al. A novel pro-inflammatory mechanism of action of resistin in human endothelial cells: up-regulation of SOCS3 expression through STAT3 activation. Biochem Biophys Res Commun. 2012 ; 422: 321-326
47. Sjoholm A, Hellerstrom C. TGF-beta stimulates insulin secretion and blocks mitogenic response of pancreatic beta-cells to glucose. Am J Physiol. 1991 ; 260 (5 Pt 1). C1046 - C1051
48. Walshe TE, Saint-Geniez M, Maharaj AS, et al. TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature. PloS one. 2009 ; 4: e5149
49. Lebrin F, Deckers M, Bertolino P, Ten Dijke P. TGF-beta receptor function in the endothelium. Cardiovascular Res. 2005 ; 65: 599-608
50. Hotamisligil GS. Mechanisms of TNF-alpha-induced insulin resistance. Exp Clin Endocrinol Diabetes. 1999 ; 107: 119-125
51. Liu SW, Qiao SB, Yuan JS, Liu DQ. Visfatin stimulates production of monocyte chemotactic protein-1 and interleukin-6 in human vein umbilical endothelial cells. Horm Metab Res. 2009 ; 41: 281-286
52. Goldstein BJ, Scalia R. Adipokines and vascular disease in diabetes. Curr Diab Rep. 2007 ; 7: 25-33
53. Lieb W, Sullivan LM, Harris TB, et al. Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individuals. Diabetes Care. 2009 ; 32: 612-616
54. Ku IA, Farzaneh-Far R, Vittinghoff E, et al. Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study. Atherosclerosis. 2011 ; 217: 503-508
55. Singh P, Peterson TE, Barber KR, et al. Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells. Biochem Biophys Res Commun. 2010 ; 392: 47-52
56. Singh P, Hoffmann M, Wolk R, et al. Leptin induces C-reactive protein expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol. 2007 ; 27: e302 - e307
57. Misztal-Dethloff B, Stepien H, Komorowski J. Effect of leptin on proliferative activity and vascular endothelial growth factor (VEGF) secretion from cultured endothelial cells HECa10 in vitro. Endocr Regul. 2004 ; 38: 161-166
58. Islami D, Bischof P, Chardonnens D. Modulation of placental vascular endothelial growth factor by leptin and hCG. Mol Hum Reprod. 2003 ; 9: 395-398
59. Yamagishi S, Inagaki Y, Amano S, et al. Up-regulation of vascular endothelial growth factor and down-regulation of pigment epithelium-derived factor messenger ribonucleic acid levels in leptin-exposed cultured retinal pericytes. Int J Tissue React. 2002 ; 24: 137-142
60. Schroeter MR, Leifheit M, Sudholt P, et al. Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion. Circ Res. 2008 ; 103: 536-544
61. Zhang P, Wang Y, Fan Y, et al. Overexpression of adiponectin receptors potentiates the antiinflammatory action of subeffective dose of globular adiponectin in vascular endothelial cells. Arterioscler Thromb Vasc Biol. 2009 ; 29: 67-74
62. Tomizawa A, Hattori Y, Kasai K, Nakano Y. Adiponectin induces NF-kappaB activation that leads to suppression of cytokine-induced NF-kappaB activation in vascular endothelial cells: globular adiponectin vs. high molecular weight adiponectin. Diab Vasc Dis Res. 2008 ; 5: 123-127
63. Devaraj S, Torok N, Dasu MR, et al. Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells:evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol. 2008 ; 28: 1368-1374
64. Malyszko J, Malyszko JS, Brzosko S, et al. Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients. J Clin Endocrinol Metab. 2004 ; 89: 4620-4627
65. Hansmann G, Rabinovitch M. The protective role of adiponectin in pulmonary vascular disease. Am J Physiol Lung Cell Mol Physiol. 2010 ; 298: L1-2
66. Kizer JR, Barzilay JI, Kuller LH, Gottdiener JS. Adiponectin and risk of coronary heart disease in older men and women. J Clin Endocrinol Metab. 2008 ; 93: 3357-3364
67. Kolasa-Trela R, Miszalski-Jamka T, Grudzien G, et al. Adiponectin, leptin, and resistin in patients with aortic stenosis without concomitant atherosclerotic vascular disease. Pol Arch Med Wewn. 2011 ; 121: 352-359
68. Aozasa N, Asano Y, Akamata K, et al. Serum apelin levels:clinical association with vascular involvements in patients with systemic sclerosis. J Eur Acad Dermatol Venereol.. 2011 ;:
69. Japp AG, Cruden NL, Amer DA, et al. Vascular effects of apelin in vivo in man. J Am Coll Cardiol. 2008 ; 52: 908-913
70. Yamawaki H, Kameshima S, Usui T, et al. A novel adipocytokine, chemerin exerts anti-inflammatory roles in human vascular endothelial cells. Biochem Biophys Res Commun. 2012 ; 423: 152-157
71. Merhi-Soussi F, Kwak BR, Magne D, et al. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovascular Res. 2005 ; 66: 583-593
72. Angel K, Provan SA, Fagerhol MK, et al. Effect of 1-year anti-TNF-alpha therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study. Am J Hypertens. 2012 ; 25: 644-650
73. Dow LE, Kauffman JS, Caddy J, et al. The tumour-suppressor Scribble dictates cell polarity during directed epithelial migration: regulation of Rho GTPase recruitment to the leading edge. Oncogene. 2007 ; 26: 2272-2282